malondialdehyde has been researched along with idoxifene in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Honda, H; Inoue, H; Ito, S; Itonaga, M; Lu, G; Nomura, M; Okamura, Y; Omoya, T; Shimizu, I; Zhou, Y | 1 |
| Cui, X; Fukuno, H; Honda, H; Inoue, H; Ito, S; Itonaga, M; Lu, G; Shimizu, I; Tamaki, K | 1 |
2 other study(ies) available for malondialdehyde and idoxifene
| Article | Year |
|---|---|
Effects of idoxifene and estradiol on NF-kappaB activation in cultured rat hepatocytes undergoing oxidative stress.
Topics: Animals; Antioxidants; Blotting, Western; Cells, Cultured; Culture Media; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Hepatocytes; L-Lactate Dehydrogenase; Lipid Peroxidation; Male; Malondialdehyde; Microscopy, Confocal; Mitochondria, Liver; NF-kappa B; Oxidative Stress; Pyrrolidines; Rats; Rats, Wistar; Tamoxifen; Thiocarbamates; Time Factors | 2001 |
Antioxidant and antiapoptotic activities of idoxifene and estradiol in hepatic fibrosis in rats.
Topics: Administration, Oral; Animals; Antioxidants; Apoptosis; bcl-Associated Death Protein; bcl-X Protein; Carrier Proteins; Dimethylnitrosamine; Disease Models, Animal; Drug Therapy, Combination; Estradiol; Estrogen Antagonists; Fluorescent Antibody Technique, Indirect; Gene Expression Regulation; Glutathione Peroxidase; Injections, Intraperitoneal; L-Lactate Dehydrogenase; Liver; Liver Cirrhosis, Experimental; Male; Malondialdehyde; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar; Superoxide Dismutase; Tamoxifen | 2004 |